Literature DB >> 6209046

Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.

M P Nair, S A Schwartz.   

Abstract

Total peripheral blood lymphocytes (PBL) and isolated subpopulations from children with Down's Syndrome (DS) and age-matched healthy controls were investigated for their (1) natural killer (NK) and antibody-dependent cellular cytotoxic activities, (2) interleukin 2 (IL-2)-induced augmentation of NK activity, (3) lectin-dependent cellular cytotoxicity (LDCC), (4) ability of serum- and culture-derived soluble suppressor factor(s) to inhibit NK activity of normal lymphocytes, and (5) capacity to produce interferon (IFN) against tumor targets in vitro. T lymphocytes from DS patients demonstrated significantly decreased NK activity against K562 target cells compared to controls. DS lymphocytes also demonstrated a significant reduction in LDCC activity and IL-2-induced enhancement of NK activity. Furthermore, the ability of DS lymphocytes to produce IFN in vitro against K562 target cells was also significantly lower than that for normal PBL. Although sera from DS patients showed a significantly greater inhibitory effect on the NK activity of allogeneic normal PBL than normal sera, culture supernates from DS lymphocytes demonstrated suppressive effects comparable to culture supernates from normal PBL. These studies suggest an association between the decreased NK activity of T-cell subpopulations and lower IFN production by PBL from patients with DS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209046     DOI: 10.1016/0090-1229(84)90312-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

1.  Neopterin: biopterin ratios in Down's syndrome.

Authors:  R J Cattell; C G Hamon; J A Corbett; J Lejeune; J A Blair
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

Review 2.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

3.  Hirschsprung's disease. Identification of risk factors for enterocolitis.

Authors:  D H Teitelbaum; S J Qualman; D A Caniano
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

4.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Serum levels of gamma interferon in patients with Down's syndrome.

Authors:  D Torre; M Broggini; C Zeroli; L Agrifoglio; V Bottà; R Casalone; G Ferrario
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

Review 6.  Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment.

Authors:  Ruth A Lewit; Korah P Kuruvilla; Ming Fu; Ankush Gosain
Journal:  Semin Pediatr Surg       Date:  2022-04-08       Impact factor: 1.900

7.  Hirschsprung's disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.